Cargando…
Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383341/ https://www.ncbi.nlm.nih.gov/pubmed/28384360 http://dx.doi.org/10.1371/journal.pone.0175659 |
_version_ | 1782520270345469952 |
---|---|
author | Nirvanappa, Anilkumar C. Mohan, Chakrabhavi Dhananjaya Rangappa, Shobith Ananda, Hanumappa Sukhorukov, Alexey Yu Shanmugam, Muthu K. Sundaram, Mahalingam S. Nayaka, Siddaiah Chandra Girish, Kesturu S. Chinnathambi, Arunachalam Zayed, M. E. Alharbi, Sulaiman Ali Sethi, Gautam Basappa, Rangappa, Kanchugarakoppal S. |
author_facet | Nirvanappa, Anilkumar C. Mohan, Chakrabhavi Dhananjaya Rangappa, Shobith Ananda, Hanumappa Sukhorukov, Alexey Yu Shanmugam, Muthu K. Sundaram, Mahalingam S. Nayaka, Siddaiah Chandra Girish, Kesturu S. Chinnathambi, Arunachalam Zayed, M. E. Alharbi, Sulaiman Ali Sethi, Gautam Basappa, Rangappa, Kanchugarakoppal S. |
author_sort | Nirvanappa, Anilkumar C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5383341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53833412017-05-03 Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo Nirvanappa, Anilkumar C. Mohan, Chakrabhavi Dhananjaya Rangappa, Shobith Ananda, Hanumappa Sukhorukov, Alexey Yu Shanmugam, Muthu K. Sundaram, Mahalingam S. Nayaka, Siddaiah Chandra Girish, Kesturu S. Chinnathambi, Arunachalam Zayed, M. E. Alharbi, Sulaiman Ali Sethi, Gautam Basappa, Rangappa, Kanchugarakoppal S. PLoS One Correction Public Library of Science 2017-04-06 /pmc/articles/PMC5383341/ /pubmed/28384360 http://dx.doi.org/10.1371/journal.pone.0175659 Text en © 2017 Nirvanappa et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Nirvanappa, Anilkumar C. Mohan, Chakrabhavi Dhananjaya Rangappa, Shobith Ananda, Hanumappa Sukhorukov, Alexey Yu Shanmugam, Muthu K. Sundaram, Mahalingam S. Nayaka, Siddaiah Chandra Girish, Kesturu S. Chinnathambi, Arunachalam Zayed, M. E. Alharbi, Sulaiman Ali Sethi, Gautam Basappa, Rangappa, Kanchugarakoppal S. Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo |
title | Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo |
title_full | Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo |
title_fullStr | Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo |
title_full_unstemmed | Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo |
title_short | Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo |
title_sort | correction: novel synthetic oxazines target nf-κb in colon cancer in vitro and inflammatory bowel disease in vivo |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383341/ https://www.ncbi.nlm.nih.gov/pubmed/28384360 http://dx.doi.org/10.1371/journal.pone.0175659 |
work_keys_str_mv | AT nirvanappaanilkumarc correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT mohanchakrabhavidhananjaya correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT rangappashobith correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT anandahanumappa correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT sukhorukovalexeyyu correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT shanmugammuthuk correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT sundarammahalingams correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT nayakasiddaiahchandra correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT girishkesturus correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT chinnathambiarunachalam correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT zayedme correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT alharbisulaimanali correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT sethigautam correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT basappa correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo AT rangappakanchugarakoppals correctionnovelsyntheticoxazinestargetnfkbincoloncancerinvitroandinflammatoryboweldiseaseinvivo |